Ally Bridge Group — Full Portfolio

CG Oncology develops an investigational oncolytic immunotherapy for urologic cancer patients, specifically targeting BCG-unresponsive non-muscle invasive bladder cancer.

BiotechHealthtechMedical Devices

AKArthur Kuan(Chairman and Chief Executive Officer)in

Co-investorsDEDecheng CapitalFOForesite CapitalLOLongitude CapitalPAPalm Drive CapitalRARA CapitalTCTCG Crossover+3 more

GRAIL develops the Galleri blood test for multi-cancer early detection using next-generation sequencing and machine learning to screen for multiple deadly cancer types before symptoms appear.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesMenlo Park, US

Jeffrey T. Huber(Director)JOJoshua Ofman, MD, MSHS(Chief Executive Officer)inAFAaron Freidin(Executive Officer)inRobert Ragusa(Executive Officer, Director)JCJennifer Cook(Executive Officer, Director)inRichard Klausner(Director)

Co-investorsAMAmino CapitalARARCH Venture PartnersBEBezos ExpeditionsBLBluebird VenturesDEDecheng CapitalDEDentsu Ventures+13 more

Pulmonx develops the Zephyr Valve, a bronchoscopic device used to treat patients with severe COPD/emphysema without surgery.

BiotechHealthtechMedical DevicesSan Jose, US

LAUREN CRISTINA(Executive Officer)inSRSri Radhakrishnan(Chief Technology Officer)inMICHAEL BAKER(Executive Officer, Director)inGlendon E. French(Chief Executive Officer and Director)DSDerrick Sung(Chief Operating Officer and Chief Financial Officer)inGeoffrey Beran Rose(Chief Commercial Officer)

Co-investorsBABand of AngelsHEHealthCapKAKaiser Permanente VenturesKLKleiner PerkinsLALatterell Venture PartnersMOMontreux Equity Partners

Rapid Micro Biosystems manufactures automated laboratory testing systems and consumables for pharmaceutical and cell therapy manufacturers to conduct microbiological quality control testing, replacing manual methods with platform-based analysis.

HealthtechLowell, US

Robert Spignesi(Executive Officer, Director)inStephen H. Delity(Executive Officer, Director)Michael J. Mullen(Executive Officer)

BoardDavid Hirsch(Director)Richard S. Kollender(Director)Fred Cohen(Director)

Co-investorsENEndeavour VisionHEHercules Capital, Inc.KLKleiner PerkinsLOLongitude CapitalXEXeraya Capital

LightForce develops generative braces using artificial intelligence and 3D printing technology to create individualized orthodontic appliances tailored to each patient.

Advanced ManufacturingAI & Machine LearningHardwareHealthtechMedical DevicesBoston, US

Alfred Griffin, DMD, PhD(Chief Product Officer / Founder)Dr. Lou Shuman, DMD, CAGS(Co-founder)ERErica Rogers(Chief Executive Officer)inAlfred Griffin(Founder)Lou Shuman(Founder)

Co-investorsKLKleiner PerkinsAMAM VenturesDIDIAMAMatrixMAMatter Venture PartnersOMOmega Venture Partners+3 more

SetPoint Medical develops an FDA-approved implantable neurostimulation device that stimulates the vagus nerve to reduce inflammation, offering a device-based treatment for adults with moderate-to-severe rheumatoid arthritis who have not responded to biologic or targeted synthetic drugs.

BiotechHealthtechMedical DevicesValencia, US

MSMurthy Simhambhatla(CEO)inDCDavid Chernoff(Chief Medical Officer (MD))YLYaakov Levine(PhD)inRSRohan Seth(Executive Officer)inKevin Tracey(Founder)

BoardBWBlake Wu(Director)in

Co-investorsNENew Enterprise Associates (NEA)NONorwest Venture PartnersTOTopspin PartnersASAsahi Kasei Corporate Venture CapitalCACatalio Capital Management, LPCICitta Capital+12 more

AdvanCell is a clinical-stage radiopharmaceutical company developing a pipeline of targeted alpha therapies for the treatment of cancers including prostate, melanoma, ovarian, breast, and lung.

BiotechHealthtechMedical DevicesCambridge, US

AAAndrew Adamovich(Director)inPLPhilina Lee(Executive Officer, Director)inAPAaron Pickett(Executive Officer)in

BoardWing Cheong Lam(Director)Nik Economopoulos(Director)Anthony Aiudi(Director)

Co-investorsBABain Capital Life SciencesCACatalio Capital Management, LPPRProto AxiomSASanofi VenturesSVSV Health InvestorsTETenmile+2 more

Aerin Medical develops non-invasive radiofrequency treatment systems for chronic nasal conditions, offering the VivAer stylus for nasal airway obstruction and RhinAer stylus for chronic rhinitis.

HealthtechMedical DevicesMountain View, US

MBMatt Brokaw(CEO & President)inDerrick Sung(Executive Officer)inMSMatthew Salkeld(Executive Officer)IRIrina Ridley(Executive Officer)inAndre Cheng(Executive Officer)inFDFred Dinger(Executive Officer, Director)in

Co-investorsLALaunchCapitalOROrbiMedQUQuesta CapitalTATargeted Technology FundsHOHorizon

BiotechCincinnati, US

RSRobert Shalwitz(Executive Officer)JGJoseph Gardner(Founder)inDuane Nash(Director)Kevin Peters(Executive Officer)Steve Pakola(Executive Officer)Ian A.W. Howes(Executive Officer)

Co-investorsCICincyTechSOSofinnova VenturesOROrbiMed

BiotechSan Diego, US

FFFrancois Ferre(Director)MMMagda Marquet(Director)Jorge Garces(Executive Officer)inGreg Hamilton(Executive Officer, Director)Carin Sandvik(Executive Officer)Jeffrey G. Black(Executive Officer)

Co-investorsBIBioBritTETelegraph Hill PartnersVIVivo CapitalWUWuXi Healthcare Ventures

Arbor develops programmable DNA editors for genetic medicine, aiming to enable functional cures for patients by addressing genetic diseases through bespoke gene editing approaches.

BiotechDigital HealthMedical DevicesCambridge, US

DADAVID ARTHUR SCOTT(Executive Officer)inWINSTON XIA YAN(Executive Officer)FZFENG ZHANG(Director)Feng Zhang, Ph.D.(Arbor Co-founder and Scientific Advisory Board Chair)DWDavid Walt, Ph.D.(Arbor Co-founder)David Scott, Ph.D.(Arbor Co-founder)

Co-investorsARARCH Venture PartnersGRGreatPoint VenturesILIllumina VenturesONOno Venture Investment, Inc.TCTCG CrossoverJAJanus Henderson Investors+5 more

Biobeat develops a cuff-less, ambulatory blood pressure monitoring system built around a proprietary PPG sensor and a platform for tracking vital signs, aimed at helping physicians diagnose and manage hypertension.

Digital HealthHealthtechMedical Devices

ABArik B.(Founder)inABArik Ben Ishay(Founder & CEO)JMJohanan May(Founder, SVP & CTO)inISIsrael Sarussi(Founder, SVP R&D)inMGMichael Gioffredi(CCO)in

BoardRaymond W. Cohen(Chairman of the Board)

Co-investorsOROrbiMedRARaptor Group

Calyxo develops medical devices for kidney stone removal, specifically a minimally invasive CVAC (Cavitation-Enabled Ablation and Clearance) system that has been FDA-cleared.

HealthtechMedical DevicesPleasanton, US

CBChris Buchko(Executive Officer)inDouglas Hughes(Executive Officer, Director)Jee Shin(Executive Officer, Director)inMark Kidd(Executive Officer)Joe Catanese(Executive Officer, Director)

BoardRDRyan Drant(Director)in

Co-investorsQUQuesta CapitalJAJanus Henderson Investors

Cardiac Dimensions develops medical technology to treat heart failure caused by functional mitral regurgitation (FMR), aiming to address underlying causes rather than symptoms.

BiotechHealthtechMedical DevicesKirkland, US

Frederick A. Stewart(Executive Officer, Director)RWRick Wypych(Executive Officer)in

BoardKurt Wheeler(Director)Nathan Every(Director)Douglas C. Fisher(Director)GBGerry Brunk(Director)in

Co-investorsAPAPERTURE Venture PartnersLULumira VenturesRERedbus VenturesCLClaret Capital PartnersJEJefferiesM.M.H. Carnegie & Co.

Launched by Samsara in partnership with CAR T pioneers, advancing a clinically validated CD22 CAR T for lymphoma.

BiotechSan Mateo, US

GCGina Chapman(Executive Officer, Director)inAnup Radhakrishnan(Executive Officer)inCassandra Gianna Luca(Director)Jeffrey Walsh(Director)Krishnan Viswanadhan(Director)

BoardAbraham Bassan(Director)

Co-investorsNENextech InvestRERed Tree VentureSASamsara BioCapitalWEWellington ManagementJAJanus Henderson InvestorsPEPerceptive Xontogeny Venture+1 more

Climb is a French wealth management service that combines advisors with technology to grow clients' assets through an open-architecture selection of investment products (life insurance, retirement PER, real estate, private equity, tax-reduction schemes, crypto).

FintechSaaS

AEAldric Emié(CEO)in

Co-investorsKIKima VenturesRARA CapitalREREDMILE

Cyteir is a clinical-stage oncology company developing CYT-0851, an oral investigational drug that inhibits monocarboxylate transporters.

BiotechHealthtechCambridge, US

Kevin Mills(Executive Officer, Director)inRGRonald Goldstein(Executive Officer)inDCDonald Corcoran(Executive Officer, Director)inMRMarkus Renschler(Director)in

BoardTimothy Romberger(Director)Barry Mills(Director)

Co-investorsDRDroia VenturesLILightstone VenturesOUOUP (Osage University Partners)SHShah Family OfficeDEDe Novo VenturesJAJanus Henderson Investors+3 more

Elevage Medical appears to be a medical or healthcare company with a team including physicians, board members, and operational staff, though the specific business activities are not detailed on this team page.

Digital HealthHealthtechMedical Devices

EMEvan Melrose(Chief Executive Officer & Partner)inMWMichael Wasserman(Chief Operating Officer & Partner)in

Co-investorsPAPatient Square Capital

Healthcare-enabling research organization that embeds clinical trials into everyday care using electronic health record data.

HealthtechAustin, US

Chad Moore(Founder)inJPJohn Potthoff(Founder)inJBJacylyn Bodmer(Chief Information Officer)KFKaren Flaherty(Vice President, Finance)inASAmy Staedtler(Chief Legal Officer)inSTScott Treiber(Chief Operating Officer)in

Co-investorsEXExcelerate Health VenturesHAHatteras Venture PartnersNONoro-Moseley PartnersNONorwest Venture PartnersSHShumway Capital

Epic CRISPR develops GEMS (Gene Expression Modulation System), a modular epigenetic editing platform that combines DNA-binding proteins, guide RNAs, and modulator proteins to create genetic medicines.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSouth San Francisco, US

Lei Stanley Qi(Scientific Founder)inASAmber Salzman(Executive Officer, Director)inHaorui Zhang(Executive Officer, Director)

BoardAndrew Lam(Director)Anran Li(Director)Jennifer King(Director)

Co-investorsSASanofi VenturesANAngelini VenturesFIFidelity InvestmentsJAJanus Henderson Investors

Galvanize provides customized technical education and training programs to help enterprise teams build skills in AI, machine learning, XP and Agile practices, data pipelines, and cloud operations.

AI & Machine LearningEdTechEnterprise SoftwareFuture of WorkDenver, US

Christopher C. Onan(Executive Officer)James Deters(President and Chief Executive Officer)LMLawrence Mandes(Managing Director, New Markets)in

BoardDaniel Pianko(Director)Tatiana Goldstein(Director)Jerrold Miller(Director)

Co-investorsGIGilmartin Capital LLCSOSofinnova PartnersTETeamworthy VenturesTHThe Colorado Impact FundVTVTF CapitalCACatalyst Investors+5 more

Galvanize Climate Solutions is an investment firm focused on the energy transition, deploying capital across areas such as climate risk analytics and clean energy.

CleantechClimate TechEnergy

VMVeery Maxwell(Founder)in

Co-investorsABABS Capital PartnersBLBlue Haven InitiativeFUFuture Positive CapitalGAGalvanize Climate SolutionsFIFidelity InvestmentsGIGilmartin Capital LLC+5 more

Galvanize Therapeutics develops surgical ablation technology using its proprietary Aliya Pulsed Electric Field (PEF) energy to destroy soft tissue cells through regulated cell death mechanisms.

BiotechHealthtechMedical DevicesRedwood City, US

DGDoug Godshall(Executive Officer, Director)inSASteve Anheier(Executive Officer)in

BoardJonathan Waldstreicher(Executive Officer)APAntoine Papiernik(Director)inSeth Harrison(Director)ZSZack Scott(Director)in

Co-investorsNONorwest Venture PartnersATATPFIFidelity InvestmentsGIGilmartin Capital LLCJAJanus Henderson InvestorsPEPerceptive Xontogeny Venture+2 more

Shanghai-based, HKEX-listed drug developer commercializing dorzagliatin, the first approved glucokinase activator for type 2 diabetes.

Li Chen(Founder)

Co-investorsARARCH Venture PartnersF-F-Prime CapitalVEVenrock6 6 Dimensions CapitalBLBlue Pool CapitalEIEight Roads Ventures+2 more

OLG Machinery, founded in 2008, trades new and certified used industrial spare parts and machinery, serving U.S. companies operating across North and South America with a focus on Mexico.

Advanced ManufacturingB2B MarketplacesLogistics & Supply Chain

Co-investorsOXOxford Investment Opportunity Network (OION)ALAltium CapitalAMAmgen VenturesDRDroia VenturesFRFrazier Healthcare PartnersNONovo Holdings+2 more

Hummingbird Bioscience is a precision biotherapeutics company developing a pipeline of novel targeted therapies for cancer, using proprietary drug discovery technologies and platforms.

AI & Machine LearningBiotechDeep TechHealthtech

PIPiers Ingram(Chief Executive Officer, Co-Founder, Executive Director)inJBJerome Boyd-Kirkup(Chief Scientific Officer, Co-Founder)inKonrad Paszkiewicz(Chief Technology Officer)inKwek Kon Yew(Chief Medical Officer)DTDipti Thakkar(Chief Operating Officer)in

Co-investorsALAltium CapitalCLClavystBioDEDecheng CapitalDRDroia VenturesFRFrazier Life SciencesKIKiwoom Investment+6 more

Chronus is a platform that connects employees for guided, AI-assisted conversations focused on career development, mentoring, community building, and change adoption in enterprise organizations.

AI & Machine LearningEnterprise SoftwareFuture of WorkHR TechSaaSNew York, US

AHAaron Hurst(Founder)in

Co-investorsEMEmpire AngelsGAGaingelsSASand Hill AngelsVOVoyager CapitalAMAmed VenturesASAscension Ventures+6 more

Insightec develops Exablate Neuro, an MRI-guided focused ultrasound platform that treats Essential Tremor and tremor-dominant Parkinson's Disease through an incision-free outpatient procedure.

HealthtechMedical DevicesTirat Carmel

Roni Karie(Vice President - Finance)SAShirel Aroshase(Vice President - Human Resources)inEZEyal Zadicario(General Manager)inMenashe Frank(Vice President - Legal)inJ(Jun (Jim) Tao(Chief Operating Officer)inMRMaurice R. Ferre(Chairman and Chief Executive Officer)in

Co-investorsCACatalio Capital Management, LPEXExigent CapitalGEGEOCJAJazzya InvestmentsKOKoch Disruptive TechnologiesKRKrillion Ventures+6 more

IsoPlexis offers the Cell Analysis Suite (CAS), software for its Beacon optofluidic platform that lets researchers design, automate, and analyze functional live single-cell workflows.

AI & Machine LearningBiotechDeep TechMedical DevicesSaaSNew Haven, US

Rong Fan(Director)Sean McKay(Executive Officer, Director)Sean Mackay(Executive Officer, Director)inRaj KhakharinJing Zhouin

BoardDaniel Wagner(Director)

Co-investorsCOConnecticut InnovationsIRIronwood CapitalNONorthpond VenturesSPSpring Mountain Capital

Mainstay provides an AI-powered platform that enables higher education institutions to engage students through proactive, personalized coaching and messaging.

AI & Machine LearningEdTechHR TechSaaSArlington, US

AMAndrew Magliozzi(Founder)inKDKirk Daulerio(Co-Founder, Vice President, Community)in

BoardKEVIN TALBOT(Director)

Co-investorsALAlumni VenturesBIBisk VenturesEAEastward Capital PartnersFUFundersClubK K Street CapitalMIMichelson 20MM Foundation+12 more

Irish company developing an advanced neurostimulation device.

HealthtechPlymouth, US

Dan Sachs(Director)PCPeter Crosby(Executive Officer, Director)inJason Hannonin

BoardMRManus Rogan(Director)inAPAntoine Papiernik(Director)in

Co-investorsFOFountain Healthcare PartnersIRIreland Strategic Investment FundSESeventure PartnersSOSofinnova PartnersVIViking GlobalGIGilde Healthcare+1 more

Neurolutions makes IpsiHand, an FDA-cleared brain-computer interface system for at-home motor rehabilitation of chronic stroke survivors with arm and hand weakness.

BiotechDigital HealthHealthtechMedical DevicesVan Nuys, US

ELEric Leuthardt(Director)inLPLeo Petrossian(Executive Officer, Director)in

BoardYuanwei Tai(Director)KRKevin Reilly(Director)inFred Khosravi(Director)inStavros Vizirgianakis(Director)

Co-investorsBIBioGenerator VenturesEXExcelestar VenturesAMAmed Ventures

OrbiMed is a global investment firm that manages public equity, private equity, and private credit/royalty strategies focused on the healthcare industry.

BiotechHealthtech

Quantum Surgical develops Epione, a robotic-assisted percutaneous ablation platform that helps interventional radiologists treat inoperable or difficult early-stage tumors without surgery by guiding needle placement for tumor destruction.

AI & Machine LearningMedical DevicesRoboticsMiami, US

BNBertin Nahum(CEO and co-founder, Quantum Surgical)inChristophe Sibillin(Executive Officer)inKurt Azarbarzin(CEO at Precision IO Group)Robert Scott(Executive Officer)Fernand Badano(Co-founder, Managing director)Lucien Blondel(Co-founder, CTO)

Co-investorsBPBpifrance

ProMIS Neurosciences is a clinical-stage biotechnology company developing antibody therapeutics that target toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's, ALS, and Parkinson's.

BiotechDeep TechHealthtechToronto, CA

Neil Cashman, M.D.(Chief Scientific Officer and Co-founder)EUGENE WILLIAMS(Chairman and Co-Founder)inROBERT GUNDEL(Executive Officer, Director)JANET CLENNETT(Executive Officer)inNeil K. Warma(President and Chief Executive Officer)inELLIOT GOLDSTEIN(Executive Officer, Director)

Co-investorsWEWellington Management

SeaGen develops automated robots that monitor aquatic ecosystems and remove pollutants while supporting the growth of beneficial species like seaweed to improve food and water security and reduce atmospheric carbon.

CleantechClimate TechRobotics

Co-investorsAEAera VCRIRidgeback CapitalRARA CapitalT.T. Rowe Price

Sonoma Biotherapeutics develops engineered regulatory T cell therapies to treat autoimmune and inflammatory diseases.

BiotechHealthtechMedical DevicesSouth San Francisco, US

JBJeffrey Bluestone(Founder)inJBJeff Bluestone, PhD(Founder and Scientific Advisor; co-founder and former President and CEO)QTQizhi Tang, PhD(Founder and Scientific Advisor)FRFred Ramsdell, PhD(Founder and Scientific Advisor)ARAlexander Rudensky, PhD(Founder and Scientific Advisor)Stephen Dilly, MBBS, PhD(President and Chief Executive Officer)

Co-investors8V8VCARARCH Venture PartnersFRFrazier Life SciencesGVGV (Google Ventures)JDJDRF T1D FundLALAV+6 more

Strateos develops remote access laboratory software and automation platforms that enable scientists to design, execute, and analyze experiments through cloud-based robotics and control systems.

AI & Machine LearningBiotechDeep TechRoboticsSaaSMenlo Park, US

CKChris Krueger(Executive Officer)inMFMark Fischer-Colbrie(Executive Officer, Director)inDLDavid Lynch, PhD(Chief Executive Officer)MSMarc Siladi(Chief Operating Officer)in

BoardJoshua Wolfe(Director)AVArmen Vidian(Director)in

Co-investorsDCDCVC (Data Collective)LULux CapitalBLBlueStone Venture PartnersTHThird Rock VenturesALAlumni VenturesDODolby Family Ventures+6 more

Syros Pharmaceuticals is a Massachusetts gene-control biotech developing small molecules that regulate disease gene expression.

BiotechCambridge, US

Nancy Simonian(CEO)Peter Wirth(Director)Mark Alles(Director)Philip Sharp(Director)Richard A. Young(Director)Sue Gail Eckhardt(Director)

Co-investorsAIAisling CapitalARARCH Venture PartnersQUQuan CapitalALAlexandriaBABain CapitalBABain Capital Life Sciences+11 more

Tectonic is a clinical-stage biotechnology company developing therapeutic proteins and antibodies that target G-Protein Coupled Receptors (GPCRs) using a proprietary platform called GEODe™.

AI & Machine LearningBiotechMedical DevicesWatertown, US

TATimothy A. Springer(Co-Founder)Andrew C. Kruse(Director)ARAlise Reicin(Executive Officer, Director)inDaniel Lochner(Executive Officer)MSMarc Schwabish(Executive Officer)inPMPeter McNamara(Executive Officer)in

Co-investorsECEcoR1 CapitalVIVida VenturesCLClarus VenturesFAFarallon EquitiesPOPolaris PartnersSOSoleus Capital

Transcarent operates a generative AI-powered health and care platform that combines medical, pharmacy, and point solutions into a single member experience, helping people navigate the healthcare system and access on-demand care.

AI & Machine LearningDigital HealthHealthtechDenver, US

GTGlen Tullman(Founder)inStephanie Peng(Executive Officer)Lee Shapiro(Executive Officer, Director)Ken Frazier(Director)Holly Maloney(Director)Hemant Taneja(Director)

Co-investors7W7wire VenturesALAlta PartnersCOCorewell Health VenturesGEGeneral CatalystGEGeodesic CapitalGRGreatPoint Ventures+9 more

Vizgen develops high-throughput spatial profiling technologies, including MERFISH-based spatial genomics and spatial proteomics tools for life science research and precision oncology.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesCambridge, US

GEGeorge Emanuel(Scientific Cofounder, VP & Portfolio Owner, Instruments)inJiang He(Scientific Cofounder, VP & Portfolio Owner, Reagents & Scientific Affairs)inXZXiaowei Zhuang(Founder; Professor, Harvard University)inFenel Eloi(Director)RCRob Carson(Chief Executive Officer)inSimona Levi(Chief Legal Officer)in

Co-investorsARARCH Venture PartnersNONorthpond Ventures6 6 Dimensions CapitalAPApplied VenturesKIKilonova CapitalPUPura Vida Investments+3 more

Venclose develops radiofrequency ablation catheters and generator systems used to treat superficial vein reflux by endovascular coagulation of blood vessels.

HardwareHealthtechMedical DevicesSan Jose, US

Greg Vislocky(Director)Charles Chon(Director)Jason Turner(Executive Officer)inPeter Osborne(Executive Officer, Director)Jerry Gibson(Executive Officer, Director)

Co-investorsSCSCP Ventures, LLC

Vida Health delivers personalized, human-centered digital health care addressing both physical and mental health.

Digital HealthHealthtechSaaSSan Francisco, US

JMJoe Murad(CEO)MRMike Rollain

BoardRFRichard Frank

Co-investorsASAspect VenturesATAtlantic Vantage PointCACanvas VenturesGEGeneral AtlanticHLHLM Investment PartnersNGNGP Capital+7 more

HealthtechCampbell, US

NNNersi Nazari(Executive Officer, Director)inSteve Zadig(Executive Officer, Director)in

BoardRichard Feachem(Director)Tom Saunders(Director)

Co-investorsASAsahi Kasei Corporate Venture CapitalESEssex Woodlands Healthcare PartnersRERevelation PartnersMVMVM Life Science PartnersTRTrinity Capital

VitalConnect develops wearable biosensor technology for remote and in-hospital patient monitoring, streaming up to 11 vital signs including live ECG to enable physicians to monitor patients recovering at home or in the hospital.

Digital HealthHealthtechMedical Devices

Co-investorsASAsahi Kasei Corporate Venture CapitalESEssex Woodlands Healthcare PartnersRERevelation PartnersTRTrinity Capital